United States · FDA National Drug Code directory
zaleplon
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0236_2a582cd7-cb01-4ec4-bd0a-d43dcd56c31c
- Product NDC
- 71335-0236
- Form
- CAPSULE
- Composition / generic term
- zaleplon
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090505
- Source listing expiry
- 20261231
Source-listed ingredients
- ZALEPLON — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (71335-0236-1) · 71335-0236-1
- 60 CAPSULE in 1 BOTTLE (71335-0236-2) · 71335-0236-2
- 90 CAPSULE in 1 BOTTLE (71335-0236-3) · 71335-0236-3
- 20 CAPSULE in 1 BOTTLE (71335-0236-4) · 71335-0236-4
- 28 CAPSULE in 1 BOTTLE (71335-0236-5) · 71335-0236-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →